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Abstract
Circulating angiogenic cells (CAC) influence vascular repair through the secre-
tion of proangiogenic factors and cytokines. While CAC are deficient in
patients with diabetes and exercise has a beneficial effect on CACs, the impact
of these factors on paracrine secretion from CAC is unknown. We aimed to
determine whether the in vitro secretion of selected cytokines and nitric oxide
(NO) from CAC is influenced by hyperglycemia and acute exercise. Colony-
forming unit CAC (CFU-CAC) were cultured from young active men (n = 9,
24  2 years) at rest and after exercise under normal (5 mmol/L) and ele-
vated (15 mmol/L) glucose. Preliminary relative multiplex cytokine analysis
revealed that CAC conditioned culture media contained three of six measured
cytokines: transforming growth factor-beta-1 (TGFb1), tumor necrosis factor
alpha (TNFa), and monocyte chemotactic protein-1 (MCP-1). Single quantita-
tive cytokine analysis was used to determine the concentration of each cyto-
kine from the four conditions. NO was measured via Griess assay. There was
a significant effect of CAC exposure to in vivo exercise on in vitro TGFb1
secretion (P = 0.024) that was independent of glucose concentration. There
was no effect of glucose or acute exercise on TNFa or MCP-1 concentration
(both P > 0.05). The concentration of NO from CFU-CAC cultured in ele-
vated glucose was lower following acute exercise (P = 0.002) suggesting that
exercise did not maintain NO secretion under hyperglycemic conditions. Our
results identify paracrine signaling factors that may be responsible for the
proangiogenic function of CFU-CAC and an influence of acute exercise and
elevated glucose on CFU-CAC soluble factor secretion.
Introduction
Vascular regenerative cell types including circulating
angiogenic cells (CAC) support vessel remodeling via dif-
ferentiation into endothelial cells and/or the secretion of
paracrine factors (Sahoo et al. 2011; Hynes et al. 2013;
Landers-Ramos et al. 2015) and have been identified via
cell surface markers (e.g., CD34, VEGFR2, CD133) and
characteristics (e.g., colony formation and acetylated LDL
uptake) (Rehman et al. 2003; Urbich et al. 2005). One
type of CACs, colony-forming CAC or CFU-CAC, has
been defined as “early outgrowth” endothelial progenitors
derived from the peripheral mononuclear fraction. Col-
ony-forming CAC are now recognized as a mixed cell
population that consist largely of hematopoietic cells
including monocytes and lymphocytes in addition to
CD34+ endothelial progenitors (Rohde et al. 2006; Yoder
et al. 2007). CFU-CAC are related to endothelial function
measured via flow-mediated brachial reactivity and con-
ventional cardiovascular disease (CVD) risk factors (Hill
et al. 2003). One explanation for this relationship is that
the complement of cells that comprise CFU-CAC secrete
factors to influence endothelial cell function (Rohde et al.
2006, 2007; Pula et al. 2009). Cytokines regulate innate
and adaptive immune responses and proinflammatory
cytokines are recognized for their role in endothelial dys-
function (Aroor et al. 2013; Shao et al. 2014). Therefore,
cell-derived factors, including cytokines and chemokines,
may be important for blood vessel homeostasis and evalu-
ation of variables that influence their release and action
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can improve our understanding of vascular function in a
variety of diseases and conditions.
Patients with type 2 diabetes (T2DM) are at higher risk
for CVD and experience greater rates of macro- and
microvascular complications than nondiabetics (Bernardi
et al. 2012) due in part to the effect of hyperglycemia on
the endothelium. Endothelial cells exposed to hyper-
glycemic conditions have increased inflammatory gene
expression (Piconi et al. 2004; Piga et al. 2007) and
decreased nitric oxide (NO) production (Ding et al. 2000;
Du et al. 2001). Many CAC populations, including early
endothelial progenitors, have been shown to be lower in
number and function in patients with diabetes compared
with controls (Tepper et al. 2002) and negatively related
to fasting plasma glucose level (Aschbacher et al. 2012).
CFU-CAC formation and skeletal muscle capillarization
was reported to be lower in adults with impaired glucose
tolerance compared with nondiabetic control subjects and
CFU-CAC number was directly associated with capillary
density (Prior and Ryan 2013). Nitric oxide signaling is
strongly related to CAC function, and appears to be defi-
cient in CAC from patients with diabetes and when CAC
are exposed to superphysiological glucose levels (Chen
et al. 2007; Cubbon et al. 2010; Heiss et al. 2010). Alter-
ation of the amount and type of factors secreted from
CFU-CAC in different glycemic environments may influ-
ence the relationship between CFU-CAC and the vascula-
ture.
Exercise is well recognized for its benefits on cardiovas-
cular health, diabetes, and blood vessel growth and repair.
Acute exercise stimulates glucose uptake into skeletal
muscle and exercise training has important insulin-sensi-
tizing and metabolic effects that improve regulation of
blood glucose. Similarly, acute bouts of exercise, exercise
training, and reduced physical activity can influence CAC.
Specifically, as little as one acute bout of exercise
increases, whereas 10 days of reduced physical activity
decreases the number of CFU-CAC from healthy active
young men (Jenkins et al. 2009; Guhanarayan et al.
2014). Furthermore, acute exercise influences gene expres-
sion and increases intracellular nitric oxide (NOi) within
cells cultured in CAC colonies (Jenkins et al. 2009). How-
ever, there is limited available evidence on effect of exer-
cise on the secretion of factors from CAC that influence
vascular growth and endothelial function (Landers-Ramos
et al. 2015). Therefore, the purpose of this study was to
evaluate whether elevated glucose levels similar to those
found in patients with poorly controlled diabetes, would
influence the release of NO and cytokine signaling factors
from CFU-CAC in vitro and whether an acute bout of
exercise altered this response. We hypothesized that CAC
cultured in elevated glucose would exhibit lower secretion
of NO and growth-related cytokines and greater release of
proinflammatory cytokines compared with normal glu-
cose. We also hypothesized that an acute bout of exercise
would normalize the glucose effect on secreted factors
from CFU-CAC.
Materials and Methods
Subjects
All protocols were approved by the University of Mas-
sachusetts Institutional Review Board. Written informed
consent was obtained from all participants. Healthy, non-
smoking, medication-free males (N = 9, 24  2 years)
with no history of CVD or diabetes were recruited for
this study. Participants were screened using health history
and physical activity questionnaires and were included if
they engaged in at least 150 min/week of moderate to vig-
orous physical activity including running to eliminate
responses to the treadmill exercise due to lack of familiar-
ity with that mode of exercise during testing. Resting
heart rate and blood pressure were also measured during
the screening visit.
Exercise and blood sampling
All testing was performed in the morning following an
8-h overnight fast. Participants refrained from regular
exercise for 48 h prior to testing to eliminate the effect of
acute exercise. Fourteen ml of blood was drawn into
tubes that contained the anticoagulant ethylenediamine
tretraacetic acid before and after an acute bout of moder-
ate treadmill exercise. Participants rested in the supine
position for 30 min prior to the preexercise blood draw.
Following cool-down, participants returned to supine rest
for 15 min prior to the postexercise blood draw. Exercise
consisted of running for 30 min at 70% of heart rate
reserve (HRRmax) with an additional 3-min warm-up
and cool down. HRRmax was calculated using the Karvo-
nen method and age-predicted maximum heart rate. Con-
tinuous heart rate monitoring and rating of perceived
exertion (RPE, Borg scale) were measured to monitor the
participants during exercise to ensure that they remained
within the prescribed intensity.
CFU-CAC isolation and culture
Peripheral blood mononuclear cells (PBMC) were isolated
from blood drawn before and after exercise via Ficoll den-
sity gradient centrifugation and cultured using the assay
developed by Hill et al. (2003) with minor modifications.
Briefly, 5 9 106 PBMC per well were plated on a fibro-
nectin plate for 48 h in either normal glucose media
(5 mmol/L, equivalent to 90 mg/dL) or high glucose media
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(15 mmol/L, equivalent to 270 mg/dL). Nonadherent cells
were collected, counted and replated at a density of
1 9 106 cells per well and cultured in either normal or high
glucose media for an additional 3 days. On the 5th day,
colony-forming units (CFU) were counted and culture
media were collected and frozen at 80°C from each con-
dition (preexercise/normal glucose, preexercise/high glu-
cose, postexercise/normal glucose, and postexercise/high
glucose) until analysis. Colony-forming units were enumer-
ated for each condition. A CFU was defined as a central
core of round cells with sprouting elongated cells around
the periphery. The endothelial lineage of these cells has
been previously confirmed via staining for CD31 and
VEGFR2 (Hill et al. 2003). CFU-CAC and have also been
shown to express T-cell and monocyte markers (Rohde
et al. 2006, 2007; Medina et al. 2010).
Cytokine secretion analysis
To determine whether the selected cytokines were secreted
from CACs, the relative amount of six candidate cytoki-
nes from CAC conditioned media under resting (nonexer-
cised, n = 2) conditions was measured using a custom
Multi-analyte ELISArray assay (Qiagen, Germantown,
MD) as per instructions from the manufacturer. Candi-
date cytokines were chosen according to their relationship
with vascular inflammation, CAC signaling, and diabetes
(Schober 2008; Yang et al. 2009; Zhang et al. 2009; Chen
et al. 2011; Desouza et al. 2011; Rissanen et al. 2012) and
included tumor necrosis factor alpha (TNFa), granulo-
cyte-macrophage colony-stimulating factor (GM-CSF),
granulocyte colony-stimulating factor (G-CSF), monocyte
chemotactic protein-1 (MCP-1), transforming growth fac-
tor-beta-1 (TGFb1), and interleukin 1 beta (IL-1b). Posi-
tive controls for each cytokine and control media, in
which no cells were cultured, were included in the analy-
sis. To quantify the absolute concentration of cytokines
for each condition (glucose concentration and exercise),
cell culture supernatants were assayed using the Single
Analyte ELISArray (Qiagen). For both assays, cell culture
media were thawed and spun at 10009 g to remove deb-
ris prior to performing the assay. All cytokines/chemoki-
nes were measured in duplicate and ELISA plates were
read at an absorbance of 450 nm with a correction absor-
bance of 570 nm. Total protein content in the media was
assayed via Pierce BCA protein assay (Thermo Scientific,
Waltham, MA). There was no effect of exercise or glucose
on total protein content (P > 0.05).
Nitric oxide assay
Nitrate/nitrite content in the media was measured with
the Griess Assay (Cayman, Ann Arbor, MI) via the manu-
facturer’s specifications. Briefly, this assay converts nitrate
to nitrite with the enzyme nitrate reductase then uses the
Griess Reagents to convert nitrite into the Azo chomo-
phore compound that which can be evaluated through
reading the absorbance at 540 nm. Media from the four
conditions were thawed on ice and spun at 10009 g to
remove debris. The supernatant was assayed in triplicate.
Interassay coefficient of variation (CV) was 6.98  0.74%
and intra-assay CV was 8.07  2.69%.
Gene expression
After 5 days of culture, cells from each of the conditions
were washed and RNA isolated via TRI reagent (Sigma-
Aldrich, St. Louis, MO) according to the manufacturer’s
specifications. RNA was quantified via absorbance at 260/
280 nm on a spectrophotometer (NanoDrop; Thermo
Scientific, Agawam, MA). One microgram of total RNA
was reverse transcribed to cDNA via iScript reverse tran-
scriptase (Bio-Rad, Hercules, CA) according to the manu-
facturer’s instructions. Gene expression was determined
for using real-time PCR (RT-PCR, CFX-96; BioRad) and
normalized to GAPDH (forward primer, 50-ACCCAGAAG
ACTGTGGATGG-30, reverse primer, 50-TTCTAG ACGGC
AGGTCAGGT-30). Transforming growth factor b1 (tgfb1)
primer sequences were forward, 50-CAACACCAT
GTGGTCTGGAG-30 and reverse. 50-GCACAGCCCAGT
GAGTACAA-30. Amplicon characteristics and primer
specificity was analyzed via dissociation curves for each
assay. Efficiency was >85% for all targets and mRNA
expression of the target gene was calculated as 2ΔCT
where ΔCT is the CT of the target gene minus GAPDH
control for each condition. Fold change in gene expres-
sion was calculated relative to the preexercise, normal glu-
cose condition, which was equal to 1.
Statistical analysis
Data are presented as means  SEM. Data for each vari-
able were tested to determine that they met the assump-
tions for statistical testing. Sample size was estimated
from a previous analysis on the acute exercise response in
CFU-CAC formation in healthy active young men (Jenk-
ins et al. 2009). According to this analysis, a sample size
of 9 would yield 80% power (a = 0.05). Two-way
repeated measures ANOVAs were used to evaluate signifi-
cant interaction (exercise 9 glucose) effect and main
effects of exercise (pre, postexercise), and glucose level
(normal, high glucose). Repeated measures ANOVAs were
followed by Tukey post hoc testing for individual com-
parisons when a significant main effect was detected.
Pearson correlations were used to evaluate relationships
between variables.
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Results
Subject characteristics
Participants were normotensive and active as they
reported over 150 min of moderate to vigorous physical
activity per week. Acute exercise yielded a RPE indicative
of the targeted moderate intensity exercise (Table 1).
Cytokines
Of the six selected cytokines screened via the multiplex
assay, TNFa, MCP-1, and TGFb1 were detected in CAC-
conditioned media (Fig. 1). Results from the single ana-
lyte ELISAs for the four conditions revealed that there
was a significant overall main effect of exercise on TGFb1
protein in the media (P = 0.024) such that TGFb1 pro-
tein increased with exercise in both normal (Fig. 2A,
P = 0.041) and high glucose conditions (P = 0.046).
There was no overall main effect of glucose on TGFb1
protein. There was a significant exercise 9 glucose inter-
action effect in Tgfb1 mRNA (P = 0.018) such that in the
high glucose condition, but not the normal glucose con-
dition, Tgfb1 mRNA was significantly higher compared
with preexercise (Fig. 2B, P = 0.04). In CAC cultured
after acute exercise, Tgfb1 mRNA was greater in high ver-
sus normal glucose conditions (P = 0.017).
There was no effect of glucose or exercise on TNFa or
MCP-1 secretion. (Fig. 3A, B). However, TNFa and MCP-
1 levels were significantly correlated with each other when
all conditions were combined (r = 0.39, P = 0.02).
Cytokine levels were not associated with CFU-CAC
number.
Nitric oxide
There was a significant interaction effect between exercise
and glucose level and glucose main effect on nitrate/ni-
trite appearance in the media (exercise 9 glucose,
P = 0.005 and glucose main effect, P = 0.031). Acute
exercise resulted in lower nitrate/nitrite concentration in
the culture media following exercise under high glucose
Table 1. Participant characteristics.
Characteristic Average  SEM
Age, year 24  2
Weight, kg 74.7  6.0
Height, m 1.72  0.02
BMI, kg/m2 24.9  1.7
SBP, mmHg 118  2
DBP, mmHg 69  2
Physical activity, h/week 7.5  1.2
Resting HR, bpm 52  2
Target HR (70% HRR), bpm 153  2
RPE (Borg scale) 12  1
Data are means  SEM. SBP, systolic blood pressure; DBP, dias-
tolic blood pressure, RPE, rating of perceived exertion. N = 9.
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conditions (Fig. 4, P < 0.002) such that there was lower
nitrate/nitrite detected following exercise in the high
glucose compared with normal glucose condition
(P < 0.001).
Circulating angiogenic cell colony formation
There was a trend toward high glucose conditions result-
ing in fewer CAC colonies formed both pre and postexer-
cise (preexercise, normal glucose 16  6 vs. high glucose
10  3 and postexercise, normal glucose 13  5 vs. high
glucose 10  3, P = 0.066). There was no overall effect of
exercise on CAC colony number (P > 0.05).
Discussion
Diabetic conditions induce changes in blood vessel integ-
rity and growth in many tissues. For example, impaired
glucose tolerance is associated with reduced skeletal mus-
cle capillary density (Prior et al. 2009). On other hand,
diabetic retinopathy is characterized by angiogenic
responses following pericyte cell death and vascular lesion
development (Sheetz and King 2002). The CAC popula-
tion evaluated herein is associated with vascular function
and cardiovascular risk (Hill et al. 2003), severity of coro-
nary artery disease (Thum et al. 2005), and reduced capil-
lary density in patients with impaired glucose tolerance
(Prior and Ryan 2013). The release of cytokines, chemoki-
nes, and growth-promoting factors is hypothesized to be
the major mechanism by which CAC influence endothe-
lial growth and angiogenesis. However, few studies have
evaluated the secretion of such factors from CAC in
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Figure 2. Transforming growth factor b1 (TGFb1) protein in
circulating angiogenic cells (CAC)-conditioned media was elevated
following acute in vivo exercise (A) and CAC gene expression was
elevated following acute in vivo exercise after exercise under the
high glucose (15 mmol/L, black bars) condition (B). P-values
represent post hoc individual comparisons. N = 9. Values are
mean  SEM.
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disease and physiological contexts. In this study, our
major findings were as follows: (1) CFU-CAC cultured
in vitro from healthy men released the signaling proteins
TGFb1, TNFa, and MCP-1, (2) CAC secretion of TGFb1
was greater following acute exercise independent of glu-
cose level, and (3) acute in vivo exercise failed to preserve
in vitro NO release from CFU-CAC in the hyperglycemic
condition.
CFU-CAC are a mixed population of cells including
cells from the hematopoietic lineage such as T cells and
monocytes (Rohde et al. 2006, 2007; Medina et al. 2010).
CFU-CAC cultures also display expression of endothelial-
related genes such as CD31, CD133, and KDR (Pula et al.
2009). CD4+ T-cell stimulation via contact with CD14+
monocytes leads to paracrine release of T-cell-derived fac-
tors that are necessary for CFU colony formation (van
Beem et al. 2008), indicating that different cell popula-
tions in CFU-CAC work cooperatively to promote
vascular effects. It has been suggested that CFU-CAC
represents the angiogenic potential of PBMC (Pula et al.
2009). CFU-CAC have been shown to secrete angiogenic
factors such as MMP-9 and IL-8 (Pula et al. 2009). In
this study, we identified three cytokines; TGFb1, MCP-1,
and TNFa that were secreted from CFU-CAC.
Transforming growth factor-beta-1 has pleiotropic
effects on the vasculature and are likely context specific.
In development, TGFb signaling is essential for proper
vasculogenesis and TGFb1 localized to endothelial cells is
required for angiogenesis (ten Dijke and Arthur 2007). In
adult vessels, TGFb1 stimulates the release of other
proangiogenic cytokines such as VEGF, and MCP-1
(Vinals and Pouyssegur 2001; Ma et al. 2007). TGFb1 has
anti-inflammatory effects as TGFb1 decreases the expres-
sion of adhesion molecules on endothelial cells (Lebastchi
et al. 2011) and activation of integrins in leukocytes lead-
ing to reduce endothelial transmigration (Basoni et al.
2005). In early stages of atherosclerosis, TGFb1 inhibits
intimal smooth muscle cell accumulation, stimulates the
extracellular matrix for repair, and controls inflammation
whereas in advanced atherosclerosis, TGFb1 is related to
excess vascular remodeling (Lutgens et al. 2002). Further-
more, upregulation of the TGF-b pathway in retinal ves-
sels is associated with proliferative diabetic retinopathy
(Gerhardinger et al. 2009).
With regard to exercise, TGFb1 has been associated
with a proangiogenic role in response to an acute bout of
physical activity (Breen et al. 1996). Other studies high-
light the role of exercise training to diminish the deleteri-
ous vascular remodeling effects of TGFb1. For example,
physical deconditioning was related to higher skeletal
muscle Tgfb1 gene expression and conduit artery wall
thickness, whereas 8 weeks of exercise training via func-
tional electrical stimulation in spinal cord injury patients
led to reduced skeletal muscle Tgfb1 expression and
decreased artery wall thickness (Lammers et al. 2013).
Furthermore, aging-associated TGFb1, collagen I, and col-
lagen III expression in carotid arteries of mice were
decreased by voluntary exercise (Fleenor et al. 2010).
Therefore, the role of TGFb1 in exercise-related adapta-
tions is likely context specific for disease status. Our data
revealed significant increases in TGFb1 protein from CAC
exposed in vivo to a single bout of moderate treadmill
exercise in both the normal and hyperglycemic in vitro
culture conditions and increased Tgfb1 gene expression in
the high glucose condition with exercise. Inconsistency in
the increase in TGFb1 gene and protein expression in the
normal glucose condition with exercise may be related to
differences in timing of the exposure, as exercise was per-
formed acutely in vivo and glucose exposure occurred
over 5 days of in vitro culture. Therefore, gene expression
in response to acute exercise may have returned to base-
line during the in vitro culture period in normal glucose
conditions. Regardless, CAC are a potential source for
TGFb1 in circulation with exercise. Interestingly, TGFb1
secretion was not associated with CFU-CAC counts in
this study. Therefore, TGFb1 does not appear to be neces-
sary for colony formation, however, the angiogenic con-
tribution of CAC-derived TGFb1 should be evaluated
further.
TNFa and MCP-1 proteins were also detected in our
CFU-CAC culture supernatant and their secretion was
significantly correlated with one another. This finding is
consistent with the evidence showing that TNFa stimu-
lates MCP-1 expression in monocytes and endothelial
cells in a diabetic environment (Yang et al. 2009). TNFa
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and MCP-1 are inflammatory cytokines that have both
detrimental and beneficial effects on the vasculature.
TNFa is an inflammatory cytokine that induces endothe-
lial cell activation and monocyte infiltration (Hopkins
2013). However, TNFa has also been shown to be impor-
tant in the growth of collateral vessels (Arras et al. 1998).
MCP-1 is a C-C family chemokine that recruits mono-
cytes and is associated with atherosclerotic lesions (Hop-
kins 2013). On other hand, in a model of hindlimb
ischemia, monocytes were recruited to the site of injury
resulting in the production of MCP-1 and stimulation of
angiogenesis (Capoccia et al. 2008). Evidence suggests
that exercise training reduces circulating TNFa and MCP-
1 levels in patients with cardiometabolic diseases (Adamo-
poulos et al. 2001; Troseid et al. 2004; Palmefors et al.
2014). Contrary to our hypothesis, neither acute exercise
nor elevated glucose significantly changed the amounts of
TNFa or MCP-1 generated by CFU-CAC suggesting that
a short-term exposures may not change the level of secre-
tion of these cytokines. However, our results that TNFa
and MCP-1 are secreted form CFU-CAC are corroborated
by van Beem et al. (2008), who also reported the appear-
ance of TNFa and MCP-1 in the same culture system.
They also reported that both cytokines were detected in
media from activated T cells, although in lower concen-
trations than complete CFU-CAC cultures suggesting that
cells other than the T cells in culture produce TNFa and
MCP-1. Rohde et al. (2006) found that in vitro vascular
networks were formed with supernatants from CFU-CAC
cultures and not supported when monocytes or T cells
were depleted from the CFU-CAC assay or when TNFa
was quenched with antibodies, indicating an important
role for TNFa in colonization. Therefore, inflammatory
cytokines play a role in vessel regeneration and repair,
however, a more complete understanding of their func-
tion in regenerative, exercise, and disease contexts is nec-
essary.
Nitric oxide bioavailability is an important factor for
vascular reactivity, vascular endothelial cell function, and
is now recognized as significant for the mobilization and
function of certain CAC types (Aicher et al. 2003; Jenkins
et al. 2009). Diabetes is associated with reduced mobiliza-
tion of CAC populations (Fadini et al. 2013) and CD34+
and CD34+/KDR+ CAC have been negatively related to
fasting and postchallenge glucose levels (Fadini et al.
2007). CFU-CAC number, CAC eNOS phosphorylation
(Ser1177), and NO in CAC culture media was reduced
when cells were incubated in 25 mmol/L glucose com-
pared with 5 mmol/L (Chen et al. 2007). In our study,
we did not observe a significant independent effect of glu-
cose on NO secretion. These disparate results may be due
to our choice of 15 mmol/L for the high glucose condi-
tion – a glucose concentration that is more similar to that
which may be observed in humans with uncontrolled dia-
betes.
We observed that NO in CAC conditioned media was
not maintained with acute exercise under high glucose
conditions. Habitual physical activity, acute exercise, and
reduced physical activity have effects on CAC NOi. Jenk-
ins et al. (2009) reported that CFU-CAC eNOS gene
expression and NOi was higher in active compared with
inactive young men at rest, but NOi was only higher in
CFU-CAC from inactive men after acute exercise. CFU-
CAC NOi has been shown to also be lower after 10 days
of reduced physical activity in active men (Guhanarayan
et al. 2014). While NOi appears to be important for CAC
function, and is influenced by physical activity, acute
exercise preconditioning could not abrogate the effects of
glucose on NO secretion in our study. It is possible that
repeated bouts of acute exercise or exercise training may
have a greater impact on preserving NO secretion upon
exposure to high levels of glucose. Oxidative stress com-
promises NO bioavailability in CAC from diabetic
patients (Jarajapu et al. 2011), and oxidative stress may
be altered in CAC with exercise (Jenkins et al. 2009,
2011) therefore future investigations should evaluate the
interaction between exercise, oxidative stress, and diabetic
conditions on the regulation of NO in CAC.
Finally, our study is not without limitations. First, since
CFU-CAC are comprised of a mixed population of cells,
it remains unclear which cells in culture are responsible
for the secretion of the investigated factors. However, we
believe that in vivo cell types contained in the CFU-CAC
culture system work in concert and may be necessary to
confer the relationship with CVD and endothelial func-
tion. Additionally, the soluble factors we evaluated herein
were chosen a priori and it is likely that there are multi-
ple other factors that may be influenced by changes in
glucose concentration and exercise. A proteomics or cyto-
kine array approach could greatly improve our under-
standing of the complement of soluble factors released by
CAC populations under various conditions. The partici-
pants in our study were young, healthy active men. It
would be informative to evaluate the effect of exercise on
CFU-CAC cytokine secretion in patients with insulin
resistance or diabetes. Lastly, conditions associated with
diabetes other than glucose (such as insulin and insulin
resistance) may impact CAC cytokine secretion therefore
future studies should evaluate other diabetes-related envi-
ronments.
Conclusion
Evaluation of the secretome of cells associated with vascu-
lar health and function may provide important informa-
tion about cardiometabolic disease. Our data contribute
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
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novel evidence that one of the major ways CAC con-
tribute to vascular health and repair, cytokine secretion,
can be influenced by exercise and conditions simulating
disease. Understanding how circulating cells promote vas-
cular repair through soluble factor secretion has the
potential to inform regenerative therapies for disease.
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